CannaLean Biotechs

CannaLean Biotechs is a pioneering biotechnology research company committed to developing innovative CBD-based solutions to improve the lives of millions of patients suffering from Dyslipidemia. Located at 14 Baruch Hirsh St, Bnei Brak, Israel 5120206, IL, CannaLean Biotechs is dedicated to the research and advancement of novel therapeutic approaches.

Through strategic partnerships and cutting-edge research, CannaLean Biotechs is at the forefront of pharmacological innovation. The company focuses on creating proprietary formulations, including Cannabidiol (CBD) and Chitosan, to address critical health challenges. CannaLean Biotechs' commitment extends to rigorous in vivo and pre-clinical studies, demonstrating significant potential in reducing cholesterol and triglyceride blood levels.

CannaLean Biotechs continues to push the boundaries of biotechnology, striving to deliver effective and groundbreaking treatments. The information will be completed soon with the support of the company’s management, showcasing their latest advancements and future goals. We invite the manager of CannaLean Biotechs to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.